ThromboGenics NV of Belgium has succeeded in raising €56 million through a private placement of its shares, well above the targeted amount of €35 million. A total of 2,944,523 new shares were placed with domestic and international investors. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
